LeMaitre Vascular, Inc. (LMAT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156857,
    "name": "LeMaitre Vascular, Inc.",
    "stock_name": "LeMaitre Vascular, Inc.",
    "full_name": "LeMaitre Vascular, Inc.",
    "name_url": "stocks-analysis/lemaitre-vascular-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "85.70",
    "chg": 2.02,
    "chgp": "2.41%",
    "dir": 1,
    "prev_price": "83.68",
    "mcapval": "2,347.50",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US5255582018",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "467.18 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lemaitre-vascular-inc-1156857-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lemaitre-vasculars-valuation-grade-changes-from-expensive-to-fair-amid-stock-price-increase-3686220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LeMaitreVascula_valuationdot_3686220.png",
        "date": "2025-11-10 15:45:42",
        "description": "LeMaitre Vascular, Inc. has recently adjusted its valuation, with a P/E ratio of 45 and a price-to-book value of 5.84. The company boasts a high dividend yield of 78.93% and a strong ROCE of 24.61%. Despite facing year-to-date challenges, it has shown resilience over three years."
      },
      {
        "title": "Is LeMaitre Vascular, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lemaitre-vascular-inc-technically-bullish-or-bearish-3673637",
        "imagepath": "",
        "date": "2025-11-05 11:21:31",
        "description": "As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current stance is bearish, with key indicators such as the MACD and Bollinger Bands both showing mildly bearish signals on a weekly and monthly basis. The moving averages indicate a mildly bullish trend on the daily timeframe, but this is overshadowed by the overall bearish sentiment in the longer timeframes. Additionally, the stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -5.30% compared to the S&P 500's 16.30%...."
      },
      {
        "title": "LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lemaitre-vasculars-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-mixed-indicators-3671390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LeMaitreVascula_technicaldot_3671390.png",
        "date": "2025-11-04 15:47:07",
        "description": "LeMaitre Vascular, Inc. has recently revised its market evaluation, with its stock priced at $86.92. The company has experienced notable volatility over the past year, with a high of $109.58 and a low of $71.42. Despite recent declines, it has shown strong long-term performance, outperforming the S&P 500 over five years."
      },
      {
        "title": "Is LeMaitre Vascular, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lemaitre-vascular-inc-technically-bullish-or-bearish-3670822",
        "imagepath": "",
        "date": "2025-11-04 11:33:02",
        "description": "As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with key indicators showing mixed signals. The MACD is mildly bearish on both weekly and monthly time frames, while the moving averages indicate a mildly bullish trend on the daily chart. The Bollinger Bands are bearish on the weekly and sideways on the monthly. Additionally, the KST is mildly bearish on both time frames, and the OBV shows a mildly bearish weekly stance but mildly bullish monthly. \n\nIn terms of performance, LeMaitre Vascular has underperformed the S&P 500 across multiple periods, with a year-to-date return of -5.67% compared to the S&P 500's 16.30%, and a one-year return of -8.39% versus 19.89%...."
      },
      {
        "title": "Is LeMaitre Vascular, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lemaitre-vascular-inc-technically-bullish-or-bearish-3666421",
        "imagepath": "",
        "date": "2025-11-03 11:32:43",
        "description": "As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD and KST are both mildly bearish, while the daily moving averages show a mildly bullish trend. The Bollinger Bands indicate a bearish stance on the weekly and a sideways trend on the monthly. The Dow Theory shows a mildly bullish trend on the weekly but no trend on the monthly. \n\nIn terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.00% compared to the S&P 500's 16.30%, and a one-year return of -2.01% versus 19.89%. However, over the longer term, the stock has outperformed the benchmark with a 3-year return of 99.56% compared to 76.66% and a 5-year return of 166.66% versus 109.18%...."
      },
      {
        "title": "Is LeMaitre Vascular, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lemaitre-vascular-inc-technically-bullish-or-bearish-3664534",
        "imagepath": "",
        "date": "2025-11-02 11:17:39",
        "description": "As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD and KST are both mildly bearish, while the daily moving averages indicate a mildly bullish trend. The Bollinger Bands show a bearish signal on the weekly timeframe and sideways on the monthly. The Dow Theory reflects a mildly bullish stance on the weekly but no trend on the monthly.\n\nIn terms of performance, LeMaitre Vascular has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.00% compared to the S&P 500's 16.30%, and a one-year return of -2.01% versus 19.89%. However, it has shown strong returns over the longer term, with a three-year return of 99.56% compared to the S&P's 76.66%...."
      },
      {
        "title": "LeMaitre Vascular Experiences Evaluation Revision Amidst Mixed Market Signals and Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lemaitre-vasculars-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-mixed-signals-3552591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/LeMaitreVascula_technicaldot_3552591.png",
        "date": "2025-09-22 18:15:23",
        "description": "LeMaitre Vascular, Inc. has recently revised its evaluation amid changing market conditions. The company's stock is priced at $92.25, with a one-year return of 2.30%, trailing the S&P 500. However, it boasts a strong five-year return of 179.88%, indicating significant long-term resilience and recovery."
      },
      {
        "title": "Is LeMaitre Vascular, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lemaitre-vascular-inc-technically-bullish-or-bearish-3546184",
        "imagepath": "",
        "date": "2025-09-20 19:26:37",
        "description": "As of 10 September 2025, the technical trend for LeMaitre Vascular, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the monthly MACD and KST indicators, which are both mildly bearish, while the weekly MACD remains bullish. The daily moving averages indicate a bullish trend, but overall, the mixed signals suggest caution. The stock has underperformed the S&P 500 over the past week and month, with returns of -0.86% and -1.70% compared to the S&P 500's gains of 1.05% and 2.33%, respectively. However, it has outperformed the benchmark over the longer term, with a 3-year return of 88.96% versus 70.41% for the S&P 500...."
      },
      {
        "title": "Is LeMaitre Vascular, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lemaitre-vascular-inc-overvalued-or-undervalued-3542799",
        "imagepath": "",
        "date": "2025-09-20 18:02:33",
        "description": "As of 23 July 2025, the valuation grade for LeMaitre Vascular, Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 45, a Price to Book Value of 5.84, and an EV to EBITDA of 30.21, which suggest that while the company is performing well, it may not be significantly undervalued.\n\nIn comparison to its peers, LeMaitre Vascular's P/E ratio of 49.77 is relatively close to TransMedics Group, Inc. at 50.23, while Veracyte, Inc. is considered expensive with a P/E of 50.97. This places LeMaitre in a competitive position within the industry, although it does not stand out as a bargain. Notably, the company's stock has underperformed against the S&P 500 over the past year, returning 5.14% compared to the index's 17.14%, which may reinforce the notion that it is fairly valued rather than..."
      }
    ],
    "total": 14,
    "sid": "1156857",
    "stock_news_url": "https://www.marketsmojo.com/news/lemaitre-vascular-inc-1156857"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics

2025-11-10 15:45:42

LeMaitre Vascular, Inc. has recently adjusted its valuation, with a P/E ratio of 45 and a price-to-book value of 5.84. The company boasts a high dividend yield of 78.93% and a strong ROCE of 24.61%. Despite facing year-to-date challenges, it has shown resilience over three years.

Is LeMaitre Vascular, Inc. technically bullish or bearish?

2025-11-05 11:21:31

As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current stance is bearish, with key indicators such as the MACD and Bollinger Bands both showing mildly bearish signals on a weekly and monthly basis. The moving averages indicate a mildly bullish trend on the daily timeframe, but this is overshadowed by the overall bearish sentiment in the longer timeframes. Additionally, the stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -5.30% compared to the S&P 500's 16.30%....

LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-11-04 15:47:07

LeMaitre Vascular, Inc. has recently revised its market evaluation, with its stock priced at $86.92. The company has experienced notable volatility over the past year, with a high of $109.58 and a low of $71.42. Despite recent declines, it has shown strong long-term performance, outperforming the S&P 500 over five years.

Is LeMaitre Vascular, Inc. technically bullish or bearish?

2025-11-04 11:33:02

As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with key indicators showing mixed signals. The MACD is mildly bearish on both weekly and monthly time frames, while the moving averages indicate a mildly bullish trend on the daily chart. The Bollinger Bands are bearish on the weekly and sideways on the monthly. Additionally, the KST is mildly bearish on both time frames, and the OBV shows a mildly bearish weekly stance but mildly bullish monthly. In terms of performance, LeMaitre Vascular has underperformed the S&P 500 across multiple periods, with a year-to-date return of -5.67% compared to the S&P 500's 16.30%, and a one-year return of -8.39% versus 19.89%....

Is LeMaitre Vascular, Inc. technically bullish or bearish?

2025-11-03 11:32:43

As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD and KST are both mildly bearish, while the daily moving averages show a mildly bullish trend. The Bollinger Bands indicate a bearish stance on the weekly and a sideways trend on the monthly. The Dow Theory shows a mildly bullish trend on the weekly but no trend on the monthly. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.00% compared to the S&P 500's 16.30%, and a one-year return of -2.01% versus 19.89%. However, over the longer term, the stock has outperformed the benchmark with a 3-year return of 99.56% compared to 76.66% and a 5-year return of 166.66% versus 109.18%....

Is LeMaitre Vascular, Inc. technically bullish or bearish?

2025-11-02 11:17:39

As of 31 October 2025, the technical trend for LeMaitre Vascular, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD and KST are both mildly bearish, while the daily moving averages indicate a mildly bullish trend. The Bollinger Bands show a bearish signal on the weekly timeframe and sideways on the monthly. The Dow Theory reflects a mildly bullish stance on the weekly but no trend on the monthly. In terms of performance, LeMaitre Vascular has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.00% compared to the S&P 500's 16.30%, and a one-year return of -2.01% versus 19.89%. However, it has shown strong returns over the longer term, with a three-year return of 99.56% compared to the S&P's 76.66%....

LeMaitre Vascular Experiences Evaluation Revision Amidst Mixed Market Signals and Strong Long-Term Performance

2025-09-22 18:15:23

LeMaitre Vascular, Inc. has recently revised its evaluation amid changing market conditions. The company's stock is priced at $92.25, with a one-year return of 2.30%, trailing the S&P 500. However, it boasts a strong five-year return of 179.88%, indicating significant long-term resilience and recovery.

Is LeMaitre Vascular, Inc. technically bullish or bearish?

2025-09-20 19:26:37

As of 10 September 2025, the technical trend for LeMaitre Vascular, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the monthly MACD and KST indicators, which are both mildly bearish, while the weekly MACD remains bullish. The daily moving averages indicate a bullish trend, but overall, the mixed signals suggest caution. The stock has underperformed the S&P 500 over the past week and month, with returns of -0.86% and -1.70% compared to the S&P 500's gains of 1.05% and 2.33%, respectively. However, it has outperformed the benchmark over the longer term, with a 3-year return of 88.96% versus 70.41% for the S&P 500....

Is LeMaitre Vascular, Inc. overvalued or undervalued?

2025-09-20 18:02:33

As of 23 July 2025, the valuation grade for LeMaitre Vascular, Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 45, a Price to Book Value of 5.84, and an EV to EBITDA of 30.21, which suggest that while the company is performing well, it may not be significantly undervalued. In comparison to its peers, LeMaitre Vascular's P/E ratio of 49.77 is relatively close to TransMedics Group, Inc. at 50.23, while Veracyte, Inc. is considered expensive with a P/E of 50.97. This places LeMaitre in a competitive position within the industry, although it does not stand out as a bargain. Notably, the company's stock has underperformed against the S&P 500 over the past year, returning 5.14% compared to the index's 17.14%, which may reinforce the notion that it is fairly valued rather than...

View All News